MedTrace Logo

ONS in Gastrointestinal Cancer Patients Undergoing Chemotherapy

NCT05980624 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2025-09-19

No results posted yet for this study

Summary

The study hypothesizes that the addition of oral nutrition supplement concurrent chemotherapy treatment to the GI cancer patients will improve the prognosis of cancer cachexia, improve health state quality of life and increase chemotherapy tolerance

Conditions

Interventions

DIETARY_SUPPLEMENT

oral nutrition supplement

patients receive ONS 300kcal in daily basis

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Alshaimaa Rabie · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2024-11-30
Completion
2025-01-16

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05980624 on ClinicalTrials.gov